Bioengineered NRF2-siRNA Is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer Cells

Pengcheng Li(Zhongnan Hospital of Wuhan University), Ai‐Ming Yu(University of California System)

Drug Metabolism and Disposition

October 23, 2017

10.1124/dmd.117.078741

Cited by 62

Related Papers

Bioengineered Noncoding RNAs Selectively Change Cellular miRNome Profiles for Cancer Therapy

|Journal of Pharmacology and Experimental Therapeutics|2018|68

Chimeric MicroRNA-1291 Biosynthesized Efficiently in Escherichia coli Is Effective to Reduce Target Gene Expression in Human Carcinoma Cells and Improve Chemosensitivity

|Drug Metabolism and Disposition|2015|60

Genetically engineered pre-microRNA-34a prodrug suppresses orthotopic osteosarcoma xenograft tumor growth via the induction of apoptosis and cell cycle arrest

|Scientific Reports|2016|43

Co-targeting of DNA, RNA, and protein molecules provides optimal outcomes for treating osteosarcoma and pulmonary metastasis in spontaneous and experimental metastasis mouse models

|Oncotarget|2017|29

Novel RNA molecular bioengineering technology efficiently produces functional miRNA agents

|RNA|2024|10